The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $15.02

Today's change+0.04 +0.27%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $15.02

Today's change+0.04 +0.27%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc up (U.S.)$0.04

Ironwood Pharmaceuticals Inc closed up Friday by (U.S.)$0.04 or 0.27% to (U.S.)$15.02. Shares have lost 3.53% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 12.28% during the last year.

Key company metrics

  • Open(U.S.) $15.12
  • Previous close(U.S.) $14.98
  • High(U.S.) $15.12
  • Low(U.S.) $14.67
  • Bid / Ask(U.S.) $11.15 / (U.S.) $18.62
  • YTD % change-1.77%
  • Volume1,268,628
  • Average volume (10-day)1,403,237
  • Average volume (1-month)1,263,881
  • Average volume (3-month)1,202,545
  • 52-week range(U.S.) $12.48 to (U.S.) $19.94
  • Beta1.40
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.97
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue65528766
Total other revenue--------
Total revenue65528766
Gross profit62528666
Total cost of revenue4120
Total operating expense106949494
Selling / general / administrative58565545
Research & development37343838
Depreciation / amortization00--3
Interest expense (income), net operating--------
Unusual expense (income)0200
Other operating expenses, total72-29
Operating income-41-42-6-28
Interest income (expense), net non-operating-9-9-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-44-53-14-33
Income after tax-44-53-14-33
Income tax, total--------
Net income-44-53-14-33
Total adjustments to net income--------
Net income before extra. items-44-53-14-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-44-53-14-33
Inc. avail. to common incl. extra. items-44-53-14-33
Diluted net income-44-53-14-33
Dilution adjustment--------
Diluted weighted average shares149148146145
Diluted EPS excluding extraordinary itemsvalue per share-0.30-0.36-0.09-0.23
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.30-0.34-0.09-0.23